Literature DB >> 22890407

High-density lipoprotein impedes glycation of low-density lipoprotein.

Nahla N Younis1, Handrean Soran, Valentine Charlton-Menys, Reena Sharma, Salam Hama, Philip Pemberton, Mohamed M Elseweidy, Paul N Durrington.   

Abstract

Glycation of low-density lipoprotein (LDL) increases its atherogenicity, but whether high-density lipoprotein (HDL) can protect LDL against glycation is not known. LDL and HDL were isolated from 32 volunteers with serum HDL cholesterol concentrations ranging from 0.76 to 2.01 (mean = 1.36) mmol/L. Glycation of LDL was induced by incubation with 0-80 mmol/L glucose for 7 days at 37°C under nitrogen in the presence of and absence of human HDL. Glycation of LDL apolipoprotein B (apoB) doubled at glucose 50 and 80 mmol/L (both p < 0.001), and this increase was ameliorated by HDL. In the absence of glucose, 0.11 (0.01) [mean (standard error, SE)] mg apoB/mg LDL protein was glycated increasing to 0.22 (0.02) mg/mg at glucose 80 mmol/L in the absence of HDL, but remaining at 0.13 (0.01) mg/mg when autologous HDL was present. Heterologous HDL from a further study of 12 healthy participants was similarly effective in impeding LDL apoB glycation. HDL impeded not only glycation but also the lipid peroxidation, free amino group consumption and increased electrophoretic mobility of LDL which accompanied glycation. HDL from participants with higher serum paraoxonase1 (PON1) was more effective in impeding glycation and the related processes. In conclusion, HDL can impede the glucose-induced glycoxidation of LDL. PON1 may be important for this function of HDL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890407     DOI: 10.1177/1479164112454309

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  6 in total

Review 1.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

2.  Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats.

Authors:  Daniela Fernandes Roxo; Carlos Alberto Arcaro; Vania Ortega Gutierres; Mariana Campos Costa; Juliana Oriel Oliveira; Tayra Ferreira Oliveira Lima; Renata Pires Assis; Iguatemy Lourenço Brunetti; Amanda Martins Baviera
Journal:  Diabetol Metab Syndr       Date:  2019-04-30       Impact factor: 3.320

Review 3.  Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Tatiana I Mel'nikova; Yuri B Porozov; Alexander A Terentiev
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

Review 4.  Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies.

Authors:  Laura Toma; Camelia Sorina Stancu; Anca Volumnia Sima
Journal:  Biomedicines       Date:  2020-12-27

5.  Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet.

Authors:  Rocio de la Iglesia; Maria L Mansego; Francisco J Sánchez-Muniz; M Angeles Zulet; J Alfredo Martinez
Journal:  EXCLI J       Date:  2014-04-09       Impact factor: 4.068

Review 6.  Antioxidant properties of HDL.

Authors:  Handrean Soran; Jonathan D Schofield; Paul N Durrington
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.